Dr. Samuel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
950 Campbell Ave
Mc 111
West Haven, CT 06516Phone+1 203-937-3848
Education & Training
University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2000- University of ChicagoResidency, Internal Medicine, 1995 - 1998
New York University School of MedicineClass of 1995
Certifications & Licensure
CT State Medical License 2000 - 2025
IL State Medical License 1995 - 2002
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- High-fat-diet-induced hepatic insulin resistanceattenuates murinelipogenesis.Leigh Goedeke, Jordan W Strober, Rebecca Suh, Lauren M Paolella, Xiruo Li
Iscience. 2024-11-15 - 2 citationsCeramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorphosphorylation pathway.Weiwei Xu, Dongyan Zhang, Yumin Ma, Rafael C Gaspar, Mario Kahn
Cell Reports. 2024-10-22 - Author Correction: Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner.Utpal B Pajvani, Carrie J Shawber, Varman T Samuel, Andreas L Birkenfeld, Gerald I Shulman
Nature Medicine. 2024-02-01
Journal Articles
- PEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed RatsArijeet K Gattu, Varman T Samuel, Violeta Popov, Daniel F Vatner, Gary Cline, Endocrinology
- PKCε Contributes to Lipid-Induced Insulin Resistance Through Cross Talk with p70S6K and Through Previously Unknown Regulators of Insulin SignalingMax C Petersen, Varman T Samuel, Proceedings of the National Academy of Sciences
Press Mentions
Dr. Brian J. Fertig: Exploring Your MetabolismApril 6th, 2022
Grant Support
- Exploring the mechanisms by which dietary fructose primarily impairs white adipose, not hepatic, function: insights from a novel ketohexokinase antisense oligonucleotideVA CONNECTICUT HEALTHCARE SYSTEM2023–2027
- Exploring the mechanisms by which dietary fructose primarily impairs white adipose, not hepatic, function: insights from a novel ketohexokinase antisense oligonucleotideVA CONNECTICUT HEALTHCARE SYSTEM2023–2027
- Exploring mitochondrialflux and lipid compartmentation in vivo to develop new therapies for alcoholic liver diseaseYALE UNIVERSITY2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
